Health Tech Hub Copenhagen

In health tech, one wrong decision can add more than a year to your timeline of your CE mark: choosing the wrong Notified Body. Review typically today takes 13–18 months, our ambition is to get it down to 10 months. I've seen founders close to tears because they had chosen the wrong notified body. One founder told us their Notified Body put their product in Class III. They switched, and the new one approved Class IIa, which was what they had aimed for. We want to stop that from happening. After working with over 130 start-ups/scale-ups, here's my advice: 1. Ask your network which Notified Bodies they used, and how it went. 2. Shortlist 2–3 that are authorised and experienced for your device type. 3. Meet all of them before you decide. Want help with the shortlist? Complete a free trial of Health Tech Pathways, and we'll help you find Notified Bodies that fit your device, free of charge. My 5 practical tips for choosing a Notified Body are here: https://lnkd.in/ecy3dsMS

Most companies ask what a membership costs. The better question: what is it worth? Here's the fee and what you get. Judge for yourself. We are a non-profit founded in 2019 and supported by the Novo Nordisk Foundation and the Danish Industry Foundation. The Hub exists to help health tech companies reach the healthcare providers and patients who actually need their solutions. 100+ companies are already benefiting. Fill out the form, and let's find out how we can help you too.

In healthtech - the wrong regulatory consultant can cost you a year and a big part of your runway. If your product is Class IIa or higher under the EU MDR, most teams will need outside help. But on a sales call, every consultant sounds the same. So, you should always remember to ask the right questions before you sign. Here’s the first one: "Have you worked on products like mine?" Ask for specific, similar cases. They tell you far more than years of experience. If this is relevant for you, or someone you know, questions 2 to 5 can be found in my blog. Link here: https://bit.ly/4s5ZVfS Try Health Tech Pathways for free. You'll see if your product falls under the MDR and which risk class it is in, and help you all the way to certification. Complete the trial, and well match you with a vetted regulatory consultant, free of charge.

Do you know every grant available that is relevant for you? Do you know in which direction health tech capital is flowing? Do you know all the health tech discounts available? Do you know where to find the best models, playbooks & projections? Do you know every conference, investor days and founder meetups? ...Orbit does. For the past seven years, we have worked alongside founders, hospitals, investors and governments. Watching, up close, what actually makes health tech progress happen. Here's what we've learned: promising products don't stall because the science is wrong or the market isn't there. They stall on the boring stuff. Internal confusion, fragmented communication, missed follow-ups, unclear responsibilities, expenses gone rogue. Momentum fades. Opportunities vanish. The worst part? None of it has anything to do with the quality or scalability of your product. Orbit makes sure you stay on track.

I’m no genie… but here’s a sneak peek into your future with Orbit. You know exactly which grants fit your stage and country. You have a pulse on where health tech capital is moving. You get negotiated rates on the services you need, without the hours of work. You have the decks, models and playbooks you need, right at your fingertips. Your calendar keeps you ahead of the European health tech ecosystem, with the conferences, investor days and founder meetups that actually matter to you. That’s Orbit. Less searching. Less guesswork. More time to build your product and reach the patients that need it. The first 100 sign-ups get €10/month, locked in for life. No contract. No onboarding call. No sales sequence. Just join, explore and leave anytime.

Money talks. The problem is it whispers. Months before anyone admits it out loud, capital is already leaning toward certain corners of health tech. By the time it's obvious, the good terms are gone and everyone's chasing the same conversation. Orbit hears it early. Not a prediction. A signal, tracked in real time, so you're never the last to know where the capital is heading. And that is just a small example of what Orbit can do.